Skip to content
Screener

Pulse Biosciences, Inc. PLSE Q1 2025 Annual earnings

Reported May 8, 2025 · After market close

Revenue-
EPS-$0.17

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$620.0K
EPS estimate-$0.35

Financials

Q1 2025

Income statement

See full
Revenue-—
Gross profit-—
Operating income-$18.0M-70.0%
Net income-$16.8M-65.7%

Balance sheet

See full
Cash & equivalents$119.3M+242%
Total debt$8.6M-3.6%
Total equity$118.5M+226%
Total assets$133.4M+171%

Cash flow

See full
Operating cash flow-$13.5M-38.3%
CapEx$45.0K+800%
Free cash flow-$13.6M-38.6%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.06B+121%
Enterprise value$950.05M+109%

Returns & leverage

See full
Return on equity-77.9%—
Debt / equity0.1×-0.2×
Current ratio15.6×+8.5×

FAQ

When did Pulse Biosciences, Inc. report Q1 2025 earnings?
Pulse Biosciences, Inc. (PLSE) reported Q1 2025 earnings on May 8, 2025 after market close.
What were Pulse Biosciences, Inc.'s Q1 2025 revenue and EPS?
Pulse Biosciences, Inc. reported revenue of - and eps of $-0.17 for Q1 2025.
How did Pulse Biosciences, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 21.4% from $-0.14.
Where can I find Pulse Biosciences, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-015517) and the 10-K periodic report (0001437749-25-009932) directly on SEC EDGAR. The filing index links above go to sec.gov.